Anthony Quintano/Civil Beat
Some Pot Bills Are Still Alive, But Recreational Use Looks Like A Nonstarter
Measures that still have a shot would allow sales of edibles at medical marijuana dispensaries and protect medical users from workplace discrimination.
Anthony Quintano/Civil Beat
Hawaii Should Be The Next State To Legalize Marijuana
UPDATED: The Legislature should not abandon bills to decriminalize or legalize recreational cannabis. And they certainly should not be stopped at the committee level.
Anthony Quintano/Civil Beat/2018
Danny De Gracia: Why A Social Conservative Like Me Wants To Legalize Pot
It’s all about economic opportunity and not letting the government tell you what you can or can’t do.
Anthony Quintano/Civil Beat
Almost Half The Senate Signs On To Bill To Legalize Recreational Marijuana
The prospects are promising for the measure in the 25-member Senate, but Gov. David Ige opposes legalization.
Anthony Quintano / Civil Beat
Big Island Dispensary Gets Green Light To Grow Medical Pot
UPDATED: Hawaiian Ethos is the first dispensary to open in Hawaii County, and the seventh statewide.
Cory Lum/Civil Beat
Chad Blair: You’d Be Surprised Which Candidates Favor Legalizing Pot
A survey sent to almost everyone on the Hawaii primary ballot found 98 who support legalization and only 30 who oppose it.
Anthony Quintano/Civil Beat
Health Beat: Marijuana Could Be Opioid Alternative — But Feds Just Say No
As we desperately seek alternatives to addictive painkillers, a federal ban on research is obstructing one promising option.
Anthony Quintano/Civil Beat
Big Island, Kauai Medical Pot Shops Still Waiting
A Kauai dispensary plans to open soon, but Big Island dispensaries have yet to start growing their first crop.
Cory Lum/Civil Beat/2018
Pesticide Compromise Reached As Conference Committee Time Expires
Measures on medical marijuana and all-mail voting are moving forward before the session wraps up next week.
Pöllö via Wikimedia Commons
Health Beat: Feds Should Stop Restricting Medical Marijuana Research
Cannabis has potential for treating various disorders, but pharmaceutical companies won’t do their thing while it’s a Schedule 1 drug.